| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor | 6.30e-05 | 2 | 159 | 2 | GO:0046857 | |
| GeneOntologyMolecularFunction | GMP reductase activity | 6.30e-05 | 2 | 159 | 2 | GO:0003920 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DAB2IP DENND5B RASA2 OBSCN ADGRB3 RCBTB2 RGS11 DENND2B SLIT2 DENND6A ARHGAP28 RAPGEF2 PREX1 | 2.17e-04 | 507 | 159 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DAB2IP DENND5B RASA2 OBSCN ADGRB3 RCBTB2 RGS11 DENND2B SLIT2 DENND6A ARHGAP28 RAPGEF2 PREX1 | 2.17e-04 | 507 | 159 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 4.37e-04 | 19 | 159 | 3 | GO:0031434 | |
| GeneOntologyMolecularFunction | phospholipid binding | DAB2IP CPNE8 RASA2 OBSCN SMURF1 ARFIP1 SYT7 SH3YL1 KCNJ2 NISCH RAPGEF2 PREX1 EPB41 | 4.55e-04 | 548 | 159 | 13 | GO:0005543 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF18A CENPF OBSCN FHOD3 CLSTN2 MAP10 ACE KIF20B DST BAIAP2L1 GLI1 NISCH SYNE2 MYH15 AATF DCLK2 SSH2 CAMSAP2 EPB41 ADSS1 | 4.72e-04 | 1099 | 159 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | calmodulin binding | 5.24e-04 | 230 | 159 | 8 | GO:0005516 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide salvage | 5.62e-06 | 16 | 158 | 4 | GO:0106380 | |
| GeneOntologyBiologicalProcess | purine nucleotide salvage | 1.17e-05 | 19 | 158 | 4 | GO:0032261 | |
| GeneOntologyBiologicalProcess | purine-containing compound salvage | 2.18e-05 | 22 | 158 | 4 | GO:0043101 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside monophosphate biosynthetic process | 2.62e-05 | 23 | 158 | 4 | GO:0009168 | |
| GeneOntologyBiologicalProcess | IMP metabolic process | 3.13e-05 | 24 | 158 | 4 | GO:0046040 | |
| GeneOntologyBiologicalProcess | IMP salvage | 3.58e-05 | 9 | 158 | 3 | GO:0032264 | |
| GeneOntologyBiologicalProcess | nucleoside monophosphate biosynthetic process | 3.60e-05 | 49 | 158 | 5 | GO:0009124 | |
| GeneOntologyBiologicalProcess | purine nucleoside monophosphate biosynthetic process | 3.70e-05 | 25 | 158 | 4 | GO:0009127 | |
| GeneOntologyBiologicalProcess | nucleotide salvage | 4.35e-05 | 26 | 158 | 4 | GO:0043173 | |
| GeneOntologyBiologicalProcess | dendrite development | DAB2IP ADGRB3 CSMD3 BTBD3 SH3GLB1 HPRT1 NLGN2 CTNND2 RAPGEF2 CAMSAP2 PREX1 | 5.67e-05 | 335 | 158 | 11 | GO:0016358 |
| GeneOntologyBiologicalProcess | liver regeneration | 1.29e-04 | 34 | 158 | 4 | GO:0097421 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 1.59e-04 | 150 | 158 | 7 | GO:0050773 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 1.74e-04 | 3 | 158 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | IMP biosynthetic process | 1.88e-04 | 15 | 158 | 3 | GO:0006188 | |
| GeneOntologyBiologicalProcess | ribonucleoside monophosphate biosynthetic process | 2.00e-04 | 38 | 158 | 4 | GO:0009156 | |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 2.29e-04 | 72 | 158 | 5 | GO:0022029 | |
| GeneOntologyBiologicalProcess | cellular metabolic compound salvage | 2.44e-04 | 40 | 158 | 4 | GO:0043094 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 2.77e-04 | 75 | 158 | 5 | GO:0021885 | |
| GeneOntologyCellularComponent | GMP reductase complex | 5.75e-05 | 2 | 159 | 2 | GO:1902560 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 8.26e-05 | 94 | 159 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | intercalated disc | 1.69e-04 | 68 | 159 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 2.25e-04 | 16 | 159 | 3 | GO:1990023 | |
| GeneOntologyCellularComponent | GLI-SUFU complex | 3.42e-04 | 4 | 159 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | sarcolemma | 6.40e-04 | 190 | 159 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | host intracellular region | 8.45e-04 | 6 | 159 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 8.45e-04 | 6 | 159 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 8.45e-04 | 6 | 159 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 8.45e-04 | 6 | 159 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 8.45e-04 | 6 | 159 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 8.45e-04 | 6 | 159 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 8.45e-04 | 6 | 159 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | Z disc | 1.06e-03 | 151 | 159 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 1.72e-03 | 166 | 159 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | cell-cell junction | AKAP6 OBSCN EVPL JAM2 JUP DST BAIAP2L1 KCNJ2 SSX2IP CTNND2 RAPGEF2 CDH13 | 1.92e-03 | 591 | 159 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | AKAP6 GTPBP4 NCOA3 RASA2 GBP7 CENPF LAMP1 HRNR KIF20B DST GBP4 CCAR1 RAPGEF2 PREX1 CDH13 SPINK5 | 2.07e-03 | 934 | 159 | 16 | GO:0048471 |
| Domain | GMPR | 7.20e-05 | 2 | 159 | 2 | IPR005993 | |
| Domain | C2 | 1.31e-04 | 131 | 159 | 7 | PF00168 | |
| Domain | SPEC | 1.51e-04 | 32 | 159 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.51e-04 | 32 | 159 | 4 | IPR018159 | |
| Domain | C2 | 1.73e-04 | 137 | 159 | 7 | SM00239 | |
| Domain | C2 | 2.16e-04 | 142 | 159 | 7 | PS50004 | |
| Domain | - | 2.78e-04 | 148 | 159 | 7 | 2.60.40.150 | |
| Domain | - | 4.27e-04 | 4 | 159 | 2 | 3.90.1460.10 | |
| Domain | IMPDH | 4.27e-04 | 4 | 159 | 2 | PF00478 | |
| Domain | IMP_DH_GMPRt | 4.27e-04 | 4 | 159 | 2 | IPR001093 | |
| Domain | IMP_DH_GMP_RED | 4.27e-04 | 4 | 159 | 2 | PS00487 | |
| Domain | IMP_DH/GMP_Rdtase_CS | 4.27e-04 | 4 | 159 | 2 | IPR015875 | |
| Domain | GTF2I | 4.27e-04 | 4 | 159 | 2 | PS51139 | |
| Domain | GTF2I | 4.27e-04 | 4 | 159 | 2 | PF02946 | |
| Domain | GTF2I | 4.27e-04 | 4 | 159 | 2 | IPR004212 | |
| Domain | C2_dom | 5.17e-04 | 164 | 159 | 7 | IPR000008 | |
| Pathway | REACTOME_NUCLEOTIDE_SALVAGE | 3.65e-05 | 23 | 118 | 4 | MM15552 | |
| Pathway | REACTOME_NUCLEOTIDE_SALVAGE | 3.65e-05 | 23 | 118 | 4 | M27831 | |
| Pathway | REACTOME_PURINE_SALVAGE | 1.54e-04 | 13 | 118 | 3 | M814 | |
| Pathway | REACTOME_PURINE_SALVAGE | 1.54e-04 | 13 | 118 | 3 | MM15438 | |
| Pubmed | AKAP6 DAB2IP ZBTB6 ATRX RASA2 GBP7 OBSCN SMURF1 HIPK2 ARFIP1 ZNF568 ERLIN1 KMT2C JUP GBP4 GLI1 GRAMD2B AATF TASOR AGRN RAD17 | 3.05e-08 | 1084 | 160 | 21 | 11544199 | |
| Pubmed | DAB2IP GTPBP4 NCOA3 CENPF KSR2 ADGRB3 GRM4 DST NISCH SYNE2 CCAR1 NLGN2 SSH2 CTNND2 RAPGEF2 CAMSAP2 AGRN RAI1 | 5.34e-07 | 963 | 160 | 18 | 28671696 | |
| Pubmed | 8.72e-07 | 284 | 160 | 10 | 29459677 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GTPBP4 CPNE8 DDX17 CENPF HRNR ERLIN1 SLIT2 CRNKL1 JUP DST ATAD3A PRMT5 HPRT1 SYNE2 AHCY MKI67 AATF HADHA | 1.28e-06 | 1024 | 160 | 18 | 24711643 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | GTPBP4 CPNE8 DDX17 CENPF EVPL HRNR NDUFB10 KIF20B ERLIN1 CRNKL1 JUP DST BAIAP2L1 ATAD3A PRMT5 AHCY MKI67 AATF HADHA TBL2 | 1.47e-06 | 1257 | 160 | 20 | 36526897 |
| Pubmed | 1.51e-06 | 234 | 160 | 9 | 36243803 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND2B JUP DST MAST4 BAIAP2L1 PRMT5 SYNE2 IQCB1 SSX2IP DCLK2 SSH2 MORC3 RAPGEF2 MAP3K21 CAMSAP2 EPB41 | 2.56e-06 | 861 | 160 | 16 | 36931259 |
| Pubmed | 2.67e-06 | 187 | 160 | 8 | 26460568 | ||
| Pubmed | DDX17 ATRX CENPF SPG11 RGS11 ERLIN1 FER1L6 GTF2IRD2B DST ANTXR2 ATAD3A SYNE2 GTF2IRD2 CCAR1 MYH15 AATF HADHA CAMSAP2 TASOR PREX1 RAI1 | 3.17e-06 | 1442 | 160 | 21 | 35575683 | |
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 28799057 | ||
| Pubmed | FNDC3B ATRX SYT7 KIF20B GGCX ERLIN1 KMT2C CRNKL1 DST PRMT5 CCAR1 WDR89 AATF DGCR8 CTNND2 CAMSAP2 TASOR AGRN PREX1 TBL2 EPB41 | 5.64e-06 | 1497 | 160 | 21 | 31527615 | |
| Pubmed | AKAP6 ATRX ADGRB3 HUNK BRWD3 SH3YL1 CRNKL1 DST NISCH AHCY CCAR1 ASTN1 DCLK2 ANKRD36 DGCR8 MORC3 CTNND2 RAPGEF2 PREX1 | 7.83e-06 | 1285 | 160 | 19 | 35914814 | |
| Pubmed | miwi, a murine homolog of piwi, encodes a cytoplasmic protein essential for spermatogenesis. | 7.87e-06 | 9 | 160 | 3 | 12062093 | |
| Pubmed | Gli3 null mice display glandular overgrowth of the developing stomach. | 7.87e-06 | 9 | 160 | 3 | 16247775 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 8.83e-06 | 220 | 160 | 8 | 35785414 | |
| Pubmed | 1.04e-05 | 225 | 160 | 8 | 12168954 | ||
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 38358805 | ||
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 19584108 | ||
| Pubmed | GTPBP4 CENPF PNPT1 CRNKL1 DST ATAD3A PRMT5 SYNE2 MKI67 CCAR1 AATF HADHA RAI1 | 1.13e-05 | 653 | 160 | 13 | 22586326 | |
| Pubmed | DDX17 MUC16 HRNR ARFIP1 BTBD3 DENND6A DST BAIAP2L1 GLI3 MKI67 DGCR8 RAPGEF2 TASOR EPB41 | 1.57e-05 | 777 | 160 | 14 | 35844135 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 EPHA6 ATRX RASA2 KSR2 OBSCN SMURF1 HIPK2 DENND2B BRWD3 SH3YL1 KMT2C ATAD3A CCAR1 NLGN2 DCLK2 RAPGEF2 EPB41 RAI1 ADSS1 | 1.79e-05 | 1489 | 160 | 20 | 28611215 |
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 18582859 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21142871 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18559511 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12351188 | ||
| Pubmed | A three-part signal governs differential processing of Gli1 and Gli3 proteins by the proteasome. | 2.10e-05 | 2 | 160 | 2 | 21921029 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29573464 | ||
| Pubmed | TDRD6 mediates early steps of spliceosome maturation in primary spermatocytes. | 2.10e-05 | 2 | 160 | 2 | 28263986 | |
| Pubmed | Palmar and plantar pads and flexion creases of genetic polydactyly mice (Pdn). | 2.10e-05 | 2 | 160 | 2 | 9918099 | |
| Pubmed | Gli3 is a Key Factor in the Schwann Cells from Both Intact and Injured Peripheral Nerves. | 2.10e-05 | 2 | 160 | 2 | 32114096 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10693759 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 38491008 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10462721 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 37621179 | ||
| Pubmed | gli, a zinc finger transcription factor and oncogene, is expressed during normal mouse development. | 2.10e-05 | 2 | 160 | 2 | 8364225 | |
| Pubmed | Dystonin deficiency reduces taste buds and fungiform papillae in the anterior part of the tongue. | 2.10e-05 | 2 | 160 | 2 | 17156752 | |
| Pubmed | Smurf1 regulation of DAB2IP controls cell proliferation and migration. | 2.10e-05 | 2 | 160 | 2 | 27036023 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28651488 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25103784 | ||
| Pubmed | Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice. | 2.10e-05 | 2 | 160 | 2 | 12925704 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 218932 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 30672020 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15809747 | ||
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 2.10e-05 | 2 | 160 | 2 | 15388857 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9659399 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12009299 | ||
| Pubmed | 2.64e-05 | 13 | 160 | 3 | 34210780 | ||
| Pubmed | 2.64e-05 | 13 | 160 | 3 | 34887903 | ||
| Pubmed | 3.35e-05 | 14 | 160 | 3 | 25581370 | ||
| Pubmed | 3.46e-05 | 40 | 160 | 4 | 20308539 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | DDX17 ATRX NDUFB10 KIF20B CRNKL1 JUP ATAD3A MKI67 CCAR1 AATF DGCR8 ZCCHC7 TASOR EPB41 RAI1 | 3.75e-05 | 954 | 160 | 15 | 36373674 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP NCOA3 KIF18A DDX17 ATRX ECHDC1 ERLIN1 PGM3 SLIT2 SH3GLB1 WDCP GLI3 HPRT1 NISCH IQCB1 MORC3 MAP3K21 CAMSAP2 | 4.03e-05 | 1321 | 160 | 18 | 27173435 |
| Pubmed | 4.17e-05 | 15 | 160 | 3 | 22340494 | ||
| Pubmed | The RNA helicase MOV10L1 binds piRNA precursors to initiate piRNA processing. | 4.17e-05 | 15 | 160 | 3 | 25762440 | |
| Pubmed | 4.17e-05 | 15 | 160 | 3 | 26439735 | ||
| Pubmed | NCOA3 RASA2 MUC16 ZNF568 FER1L6 SYNE2 AATF CTNND2 PREX1 UTY TBL2 RAI1 | 4.29e-05 | 638 | 160 | 12 | 31182584 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GTPBP4 FNDC3B DDX17 RASA2 THUMPD3 KIF20B ERLIN1 CRNKL1 JUP DST ATAD3A TK1 AHCY MKI67 CCAR1 AATF HADHA AGRN | 5.49e-05 | 1353 | 160 | 18 | 29467282 |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 10102269 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 26010061 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 27163153 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 9813312 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 26542734 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 16840550 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 5806166 | ||
| Pubmed | CRISPR-Cas9 effectors facilitate generation of single-sex litters and sex-specific phenotypes. | 6.29e-05 | 3 | 160 | 2 | 34862376 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 28965847 | ||
| Pubmed | Desulfation of Heparan Sulfate by Sulf1 and Sulf2 Is Required for Corticospinal Tract Formation. | 6.29e-05 | 3 | 160 | 2 | 29062064 | |
| Pubmed | Gli family members are differentially expressed during the mitotic phase of spermatogenesis. | 6.29e-05 | 3 | 160 | 2 | 9178901 | |
| Pubmed | Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. | 6.29e-05 | 3 | 160 | 2 | 8378770 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 31425296 | ||
| Pubmed | Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. | 6.29e-05 | 3 | 160 | 2 | 24065825 | |
| Pubmed | Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. | 6.29e-05 | 3 | 160 | 2 | 16162649 | |
| Pubmed | Structural basis of SUFU-GLI interaction in human Hedgehog signalling regulation. | 6.29e-05 | 3 | 160 | 2 | 24311597 | |
| Pubmed | HIPK2 sustains apoptotic response by phosphorylating Che-1/AATF and promoting its degradation. | 6.29e-05 | 3 | 160 | 2 | 25210797 | |
| Pubmed | Sonic Hedgehog-induced activation of the Gli1 promoter is mediated by GLI3. | 6.29e-05 | 3 | 160 | 2 | 10075717 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 28301542 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 8387379 | ||
| Pubmed | Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling. | 6.29e-05 | 3 | 160 | 2 | 16571352 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 29722127 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 10349621 | ||
| Pubmed | Conserved modularity and potential for alternate splicing in mouse and human Slit genes. | 6.29e-05 | 3 | 160 | 2 | 12141424 | |
| Pubmed | Different expression patterns of Gli1-3 in mouse embryonic maxillofacial development. | 6.29e-05 | 3 | 160 | 2 | 22178118 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 20450760 | ||
| Pubmed | GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair. | 6.29e-05 | 3 | 160 | 2 | 35780181 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 20398247 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 15100712 | ||
| Pubmed | UHRF1 suppresses retrotransposons and cooperates with PRMT5 and PIWI proteins in male germ cells. | 6.29e-05 | 3 | 160 | 2 | 31624244 | |
| Pubmed | Common variation in GPC5 is associated with acquired nephrotic syndrome. | 6.29e-05 | 3 | 160 | 2 | 21441931 | |
| Pubmed | GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis. | 6.29e-05 | 3 | 160 | 2 | 29128363 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 20680316 | ||
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 6.54e-05 | 91 | 160 | 5 | 34445801 | |
| Pubmed | 7.15e-05 | 218 | 160 | 7 | 19460752 | ||
| Pubmed | 7.41e-05 | 18 | 160 | 3 | 16854408 | ||
| Pubmed | 7.41e-05 | 18 | 160 | 3 | 14645126 | ||
| Pubmed | 7.41e-05 | 18 | 160 | 3 | 19570847 | ||
| Pubmed | 8.77e-05 | 19 | 160 | 3 | 32234482 | ||
| Pubmed | APC sets the Wnt tone necessary for cerebral cortical progenitor development. | 8.77e-05 | 19 | 160 | 3 | 28916710 | |
| Pubmed | Cell-autonomous activation of Hedgehog signaling inhibits brown adipose tissue development. | 8.77e-05 | 19 | 160 | 3 | 25848030 | |
| Pubmed | 8.77e-05 | 19 | 160 | 3 | 24886827 | ||
| Pubmed | 9.31e-05 | 98 | 160 | 5 | 34943047 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 1.25e-04 | 137 | 160 | 5 | chr1p22 | |
| Cytoband | 3p14.3 | 1.57e-04 | 30 | 160 | 3 | 3p14.3 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 3.99e-04 | 25 | 105 | 3 | 504 | |
| GeneFamily | EF-hand domain containing|Plakins | 9.14e-04 | 8 | 105 | 2 | 939 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.46e-03 | 10 | 105 | 2 | 830 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | IL10RA KRT26 GBP7 DENND2B KIF20B ANTXR2 GBP4 SSX2IP ASB2 RAPGEF2 | 4.25e-07 | 200 | 159 | 10 | M9321 |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP | COQ10B ERLIN1 BAIAP2L1 TK1 GRAMD2B MKI67 ASB2 RAPGEF2 DNASE1L3 | 3.88e-06 | 200 | 159 | 9 | M5994 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 KIF18A ECHDC1 THUMPD3 HIPK2 SPG11 ZNF397 KIF20B SULF2 SYNE2 MKI67 CCAR1 CTNND2 TASOR RAD17 | 1.18e-05 | 656 | 159 | 15 | M18979 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.34e-05 | 192 | 157 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.34e-05 | 192 | 157 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | BDP1 GTPBP4 KIF18A ATRX CENPF ECHDC1 KIF20B GLI3 SYNE2 MKI67 CCAR1 | 2.09e-05 | 311 | 157 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_top-relative-expression-ranked_1000 | GTPBP4 ZBTB6 CENPF THUMPD3 RCBTB2 FHOD3 KIF20B BRWD3 SH3YL1 SLIT2 PNPT1 MEX3A INSL6 SSX2IP AATF SSH2 CTNND2 MAP3K21 | 2.19e-05 | 787 | 157 | 18 | gudmap_kidney_e10.5_UretericTip_HoxB7_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | KIF18A KLK10 EPHA6 ATRX CENPF KSR2 HIPK2 FHOD3 CLSTN2 KIF20B SLIT2 WDCP GLI3 SYNE2 SSX2IP MKI67 TIGD3 CCAR1 ASTN1 CTNND2 EPB41 | 3.69e-05 | 1060 | 157 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | DENND5B ATRX CENPF ADGRB3 HIPK2 FHOD3 ZKSCAN2 CLSTN2 KIF20B JAM2 SLIT2 KCNJ2 SYNE2 SLIT3 CCAR1 ASTN1 DCLK2 CTNND2 EPB41 VCAM1 | 4.13e-05 | 986 | 157 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 KIF18A ATRX CENPF ARFIP1 KIF20B DST GLI3 CCAR1 MORC3 RAPGEF2 PREX1 EPB41 | 4.78e-05 | 469 | 157 | 13 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.89e-05 | 91 | 157 | 6 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 5.92e-05 | 232 | 157 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | KIF18A KLK10 EPHA6 ATRX CENPF KSR2 HIPK2 FHOD3 CLSTN2 GRM4 KIF20B JAM2 SLIT2 WDCP GLI3 SYNE2 SSX2IP MKI67 TIGD3 CCAR1 ASTN1 CTNND2 EPB41 VCAM1 | 1.14e-04 | 1414 | 157 | 24 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | DENND5B BDP1 GTPBP4 KIF18A ATRX CENPF ECHDC1 ADGRB3 FHOD3 ZKSCAN2 KIF20B JAM2 SLIT2 GLI3 SYNE2 MKI67 CCAR1 ASTN1 CTNND2 | 1.33e-04 | 989 | 157 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | DENND5B KIF18A ATRX CENPF ECHDC1 HIPK2 ZNF397 GRM4 KIF20B BRWD3 SLIT2 SULF2 TRMT44 INSL6 KCNJ2 WDCP GLI3 SYNE2 MKI67 CCAR1 PREX1 EPB41 | 1.39e-04 | 1252 | 157 | 22 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.99e-04 | 161 | 157 | 7 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-08 | 195 | 160 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-08 | 195 | 160 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.20e-08 | 197 | 160 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-07 | 170 | 160 | 8 | 670027daec5a10dfa12246f1497b58db21d32a22 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 2.02e-07 | 171 | 160 | 8 | dfd4a15ab68ef5a9a1954b1b1540ae04017885a6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.32e-07 | 189 | 160 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-07 | 192 | 160 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.27e-07 | 194 | 160 | 8 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.48e-07 | 195 | 160 | 8 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.92e-07 | 197 | 160 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.92e-07 | 197 | 160 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.15e-07 | 198 | 160 | 8 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.39e-07 | 199 | 160 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.63e-07 | 200 | 160 | 8 | 0f6620a5baace704518d42fa2f3f90751240f7dd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 7.26e-07 | 139 | 160 | 7 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 169 | 160 | 7 | 3f8aa6d2f9aa060ae1a0ea3eb47e794099fc2c2c | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 169 | 160 | 7 | 26de495c7562e0740689d0f78e803698e3e793db | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-DC1|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.68e-06 | 169 | 160 | 7 | 488ba50631a64cb9e0d69219491c66ac824c9e7d | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 169 | 160 | 7 | b798b91567d2f49082e2d8a337169f241c8d2080 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 177 | 160 | 7 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | PBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 3.64e-06 | 177 | 160 | 7 | 974305e4c0eff90134c4e58cf11b955d1eee0501 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-06 | 179 | 160 | 7 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.92e-06 | 179 | 160 | 7 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-06 | 179 | 160 | 7 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.37e-06 | 182 | 160 | 7 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.70e-06 | 184 | 160 | 7 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 4.70e-06 | 184 | 160 | 7 | ee295f6fa898da53883e1358b17f2c2dd177e9a7 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.70e-06 | 184 | 160 | 7 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.04e-06 | 186 | 160 | 7 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-06 | 187 | 160 | 7 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-06 | 187 | 160 | 7 | 7170694a1b86fe8d84d96c880ffe57af09bdc026 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.23e-06 | 187 | 160 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-06 | 187 | 160 | 7 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.80e-06 | 190 | 160 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.80e-06 | 190 | 160 | 7 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 6.00e-06 | 191 | 160 | 7 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 6.00e-06 | 191 | 160 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.00e-06 | 191 | 160 | 7 | 0f9443da0f73d07456142fae08b2dc92a5b7b592 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.00e-06 | 191 | 160 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.21e-06 | 192 | 160 | 7 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.43e-06 | 193 | 160 | 7 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.43e-06 | 193 | 160 | 7 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 6.65e-06 | 194 | 160 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.65e-06 | 194 | 160 | 7 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.65e-06 | 194 | 160 | 7 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.65e-06 | 194 | 160 | 7 | 2e3a64bda7c76fd0c99e93de0215f236e8045d83 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.65e-06 | 194 | 160 | 7 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.65e-06 | 194 | 160 | 7 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.65e-06 | 194 | 160 | 7 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.65e-06 | 194 | 160 | 7 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.87e-06 | 195 | 160 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.87e-06 | 195 | 160 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 6.87e-06 | 195 | 160 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.11e-06 | 196 | 160 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | Transverse-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 7.35e-06 | 197 | 160 | 7 | a0a096e8e80763a92d5d7396eb678a4587771a3a | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_basal-Dividing_Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-06 | 197 | 160 | 7 | 0a6754a5109bec0d0de42adbfdf4db43ff60c3d2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.59e-06 | 198 | 160 | 7 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 7.59e-06 | 198 | 160 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.59e-06 | 198 | 160 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.85e-06 | 199 | 160 | 7 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.85e-06 | 199 | 160 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 7.85e-06 | 199 | 160 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.85e-06 | 199 | 160 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.11e-06 | 200 | 160 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.11e-06 | 200 | 160 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 8.11e-06 | 200 | 160 | 7 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.88e-06 | 136 | 160 | 6 | 9d7080f695de4ef183e3dbdc18ba464a3b8e3469 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.15e-05 | 156 | 160 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-05 | 161 | 160 | 6 | 1011094c54381d52566e24c92f89f2efc2aa3eea | |
| ToppCell | COVID-19_Severe-multiplets|World / disease group, cell group and cell class | 2.76e-05 | 163 | 160 | 6 | 6db4271c2d47a9c333964f36d2c32207115e52cd | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.76e-05 | 163 | 160 | 6 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 164 | 160 | 6 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 164 | 160 | 6 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 164 | 160 | 6 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.06e-05 | 166 | 160 | 6 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 3.06e-05 | 166 | 160 | 6 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 166 | 160 | 6 | 971ee6602a1e751f453f9d823295e63dadce62bf | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.16e-05 | 167 | 160 | 6 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 168 | 160 | 6 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.38e-05 | 169 | 160 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 170 | 160 | 6 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.49e-05 | 170 | 160 | 6 | b04e2f84024baaae9b4ff19bdac8c69afdb92a76 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 170 | 160 | 6 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 170 | 160 | 6 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 171 | 160 | 6 | 355a27ea88410a84210f7e4298c7c4f90cf2f8a9 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 173 | 160 | 6 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-05 | 173 | 160 | 6 | 20f7dfe7d92a3dbec9da9a1f3185aa10cb8f0a3c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-05 | 173 | 160 | 6 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 173 | 160 | 6 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 173 | 160 | 6 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.10e-05 | 175 | 160 | 6 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.10e-05 | 175 | 160 | 6 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 175 | 160 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-05 | 176 | 160 | 6 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.37e-05 | 177 | 160 | 6 | 6da88c358b3a2e47fa3472217a38b6b00ad7b280 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.37e-05 | 177 | 160 | 6 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 4.37e-05 | 177 | 160 | 6 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.80e-05 | 49 | 95 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Drug | HPPR -MP | 3.49e-08 | 6 | 160 | 4 | CID000086479 | |
| Drug | thiopurinol | 2.23e-06 | 14 | 160 | 4 | CID000667510 | |
| Drug | 1-nitrosopyrene | 3.02e-06 | 15 | 160 | 4 | CID000104777 | |
| Drug | 6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A | 1.02e-05 | 195 | 160 | 9 | 667_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A | 1.25e-05 | 200 | 160 | 9 | 665_DN | |
| Drug | roxarsone | 2.65e-05 | 25 | 160 | 4 | CID000005104 | |
| Drug | 1-nitropyren-6-ol | 3.94e-05 | 10 | 160 | 3 | CID000104988 | |
| Drug | ACVDP | 3.94e-05 | 10 | 160 | 3 | CID000501523 | |
| Drug | AC1LAQAP | 3.94e-05 | 10 | 160 | 3 | CID000493157 | |
| Drug | 1-nitropyren-8-ol | 3.94e-05 | 10 | 160 | 3 | CID000105022 | |
| Drug | 3-nitrofluoranthen-6-ol | 4.91e-05 | 2 | 160 | 2 | CID000146572 | |
| Drug | 3-nitrofluoranthen-9-ol | 4.91e-05 | 2 | 160 | 2 | CID000146573 | |
| Drug | 3-nitrofluoranthen-8-ol | 4.91e-05 | 2 | 160 | 2 | CID000146567 | |
| Drug | 1,3,6-trinitropyrene | 4.91e-05 | 2 | 160 | 2 | CID000053229 | |
| Drug | AC1L25J4 | 4.91e-05 | 2 | 160 | 2 | CID000041328 | |
| Drug | 2-methylcarbazole | 4.91e-05 | 2 | 160 | 2 | CID000019290 | |
| Drug | m-nitrobenzamidine hydrochloride | 4.91e-05 | 2 | 160 | 2 | CID000165122 | |
| Drug | 2-hydroxypropyl | 4.91e-05 | 2 | 160 | 2 | CID000141483 | |
| Drug | 2-nitrobenzofuran | 4.91e-05 | 2 | 160 | 2 | CID000036328 | |
| Drug | 1,3,6,8-tetranitropyrene | 4.91e-05 | 2 | 160 | 2 | CID000034321 | |
| Disease | Liver carcinoma | KIF18A STAB2 CENPF ACE SLIT2 PNPT1 KMT2C TK1 GLI1 MKI67 DNASE1L3 CDH13 VCAM1 | 2.63e-06 | 507 | 153 | 13 | C2239176 |
| Disease | visceral adipose tissue measurement, body mass index | 9.21e-05 | 87 | 153 | 5 | EFO_0004340, EFO_0004765 | |
| Disease | Atrial Fibrillation | 1.94e-04 | 160 | 153 | 6 | C0004238 | |
| Disease | von Willebrand factor measurement | 2.07e-04 | 56 | 153 | 4 | EFO_0004629 | |
| Disease | IGF-1 measurement | DENND5B FNDC3B STAB2 EPHA6 RASA2 MEIOB INSL6 SYNE2 SLIT3 ASTN1 | 2.44e-04 | 488 | 153 | 10 | EFO_0004627 |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 2.55e-04 | 24 | 153 | 3 | DOID:3827 (biomarker_via_orthology) | |
| Disease | interstitial cystitis (is_marker_for) | 2.64e-04 | 5 | 153 | 2 | DOID:13949 (is_marker_for) | |
| Disease | Colorectal Carcinoma | AKAP6 OBSCN CLSTN2 CSMD3 KMT2C TK1 GLI3 MKI67 CCAR1 CTNND2 CAMSAP2 DNASE1L3 | 3.13e-04 | 702 | 153 | 12 | C0009402 |
| Disease | blood rubidium measurement | 3.26e-04 | 26 | 153 | 3 | EFO_0021529 | |
| Disease | unipolar depression, depressive symptom measurement | 3.26e-04 | 26 | 153 | 3 | EFO_0003761, EFO_0007006 | |
| Disease | Carcinoma, Granular Cell | 3.54e-04 | 116 | 153 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.54e-04 | 116 | 153 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.54e-04 | 116 | 153 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.54e-04 | 116 | 153 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.54e-04 | 116 | 153 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 3.54e-04 | 116 | 153 | 5 | C0001418 | |
| Disease | Substance abuse problem | 3.54e-04 | 116 | 153 | 5 | C0740858 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 3.65e-04 | 27 | 153 | 3 | EFO_0004629, EFO_0004630 | |
| Disease | Prostatic Neoplasms | DAB2IP NCOA3 STAB2 CENPF ACE KMT2C JUP ANTXR2 ATAD3A CDH13 SPINK5 | 3.87e-04 | 616 | 153 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | DAB2IP NCOA3 STAB2 CENPF ACE KMT2C JUP ANTXR2 ATAD3A CDH13 SPINK5 | 3.87e-04 | 616 | 153 | 11 | C0376358 |
| Disease | ubiquitin-like protein ISG15 measurement | 3.95e-04 | 6 | 153 | 2 | EFO_0021875 | |
| Disease | alcohol consumption measurement | AKAP6 CPNE8 RASA2 ADGRB3 CSMD3 ERLIN1 BTBD3 MAST4 GLI3 FAM227A AATF ANKRD36 CTNND2 HAS3 AGRN CDH13 | 7.53e-04 | 1242 | 153 | 16 | EFO_0007878 |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 9.39e-04 | 9 | 153 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 1.35e-03 | 156 | 153 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.35e-03 | 156 | 153 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.35e-03 | 156 | 153 | 5 | C2585653 | |
| Disease | pars orbitalis volume measurement | 1.42e-03 | 11 | 153 | 2 | EFO_0010320 | |
| Disease | suicide behaviour measurement | 1.45e-03 | 43 | 153 | 3 | EFO_0006882 | |
| Disease | Malignant neoplasm of breast | AKAP6 NCOA3 FNDC3B KLK10 CENPF OBSCN ATP6AP1L SULF2 GLI1 WDCP NISCH SYNE2 MKI67 DNASE1L3 | 1.45e-03 | 1074 | 153 | 14 | C0006142 |
| Disease | Gastrointestinal Stromal Sarcoma | 1.88e-03 | 47 | 153 | 3 | C3179349 | |
| Disease | systemic lupus erythematosus (is_marker_for) | 1.88e-03 | 47 | 153 | 3 | DOID:9074 (is_marker_for) | |
| Disease | high density lipoprotein particle size measurement | 1.97e-03 | 170 | 153 | 5 | EFO_0008592 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 2.01e-03 | 13 | 153 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | Gastrointestinal Stromal Tumors | 2.24e-03 | 50 | 153 | 3 | C0238198 | |
| Disease | precuneus cortex volume measurement | 2.33e-03 | 14 | 153 | 2 | EFO_0010326 | |
| Disease | diacylglycerol 42:7 measurement | 2.33e-03 | 14 | 153 | 2 | EFO_0020068 | |
| Disease | cognitive function measurement, self reported educational attainment | 2.61e-03 | 355 | 153 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | monoclonal gammopathy | 2.65e-03 | 53 | 153 | 3 | EFO_0000203 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 3.06e-03 | 16 | 153 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | Drug habituation | 3.08e-03 | 115 | 153 | 4 | C0013170 | |
| Disease | Drug abuse | 3.08e-03 | 115 | 153 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.08e-03 | 115 | 153 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.08e-03 | 115 | 153 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.08e-03 | 115 | 153 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.08e-03 | 115 | 153 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.08e-03 | 115 | 153 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.08e-03 | 115 | 153 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.08e-03 | 115 | 153 | 4 | C0029231 | |
| Disease | ovarian cancer (is_implicated_in) | 3.10e-03 | 56 | 153 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Hypertrophic Cardiomyopathy | 3.26e-03 | 57 | 153 | 3 | C0007194 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 3.45e-03 | 17 | 153 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | sphingomyelin 14:0 measurement | 3.45e-03 | 17 | 153 | 2 | EFO_0010390 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 3.45e-03 | 17 | 153 | 2 | OBA_2045173 | |
| Disease | hippocampal tail volume | 4.31e-03 | 19 | 153 | 2 | EFO_0009398 | |
| Disease | end stage renal disease (implicated_via_orthology) | 4.77e-03 | 20 | 153 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | brain connectivity measurement | 4.99e-03 | 400 | 153 | 7 | EFO_0005210 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQRKSQYSCKGSELR | 101 | F5H4B4 | |
| CSSGLLVYKDKLRIN | 416 | P11171 | |
| TSTKEKQPCSDRYRI | 131 | A6H8Y1 | |
| KQASCSGDEYRSLKV | 196 | O95394 | |
| RLVGKSSAVCRKSSY | 2601 | Q7Z407 | |
| QCDIYRSTKAGAKLR | 556 | P12821 | |
| KKENSELRRTVYLCT | 1271 | O60242 | |
| RESCFYRKLTDTSKD | 971 | Q8IX12 | |
| SCYSKLKEQLETSRR | 136 | Q9Y2D8 | |
| SNKSRETPLYKACER | 201 | Q96Q27 | |
| SDVISKRSGYCKTRL | 111 | Q9H8M1 | |
| RLKLAQFDYGRKCSE | 551 | Q9NVI7 | |
| SCALKYSDIRTGRES | 311 | O75477 | |
| KKCTNRERIGQDSAY | 386 | Q14833 | |
| DSLYRCKQLKRAALG | 121 | Q9BZE4 | |
| LKKARCESQRGLYVA | 731 | O00468 | |
| YKCTRQIISEKLGRG | 136 | P53367 | |
| KEAKISRSLGASVYC | 161 | P58335 | |
| GRQSLLRDAKDCKST | 101 | Q6RI45 | |
| SCGSAEYSAKIELKR | 416 | Q9Y2F9 | |
| LNRYKRAGESQDKCT | 41 | Q9UKU9 | |
| KRNGETLAKTIACYS | 1556 | A6QL64 | |
| SDCKGNDKLRYEVSS | 56 | P55290 | |
| ESCRSKDRKVLYTGA | 126 | Q8WYQ5 | |
| DRETYSEKSLQKLCG | 311 | Q9H4D0 | |
| SCYSVDRGKRKTGTL | 306 | P78524 | |
| LSDSKKRSLYDRAGC | 56 | Q8NHS0 | |
| ISLKERKTDYECTGS | 1081 | Q9UQB3 | |
| KNFRCISDRKLDSTG | 621 | O14525 | |
| RLDSLNGKKIACLSY | 91 | O95199 | |
| AGLSCDRQRLLAKDY | 36 | Q7Z5J4 | |
| RLKYISSCKRLRSDS | 1576 | Q7Z5J4 | |
| SKTDDLGSLRLNICY | 301 | Q15283 | |
| GKILYCKRASLTELD | 401 | O75943 | |
| AERTEYQSLCKSKLL | 21 | Q5JT25 | |
| NIRKRGTLVDYEKDC | 131 | O94810 | |
| IYCNLLDGEERKSKS | 386 | Q7Z3Y9 | |
| CSARDLAEKKYILSN | 356 | P63252 | |
| KKLCNSTYRRLGTDE | 71 | Q5VTT2 | |
| KYFTTSDRRKGQRCE | 181 | Q8N635 | |
| CLDDVLYARTTGKLK | 236 | Q5VWQ8 | |
| LYSGCRLTSLRSEKD | 12436 | Q8WXI7 | |
| EGCTKAYSRLENLKT | 551 | P10071 | |
| SSSRRIQKGEELCYD | 4871 | Q8NEZ4 | |
| RRSTVSLLDTYQKCG | 116 | Q9H2X6 | |
| ISDKRTGKNSCYENI | 681 | Q9P2G4 | |
| RALKKSVCSGRELYL | 261 | Q9NTX5 | |
| LCSEYRKLVRNGKLA | 366 | Q9NQ38 | |
| LCSEYRKSRKNGRLF | 436 | Q9NQ38 | |
| LRNECSSVYSKGRIL | 476 | Q03001 | |
| RKQYCTLKEAGLSNA | 581 | Q8NI77 | |
| DKVRYRCSSNLVLTG | 171 | P06681 | |
| LCKGRTLYSVVRDAK | 741 | Q6VAB6 | |
| GNRCSESSTLLEKYK | 381 | Q8N568 | |
| CLVRSKYNDDIRKGI | 41 | Q9Y3D6 | |
| RQLDKCSIERDQYKS | 821 | Q14149 | |
| RKSGKQYSIEAALRC | 1741 | Q92817 | |
| GAYSSARKCLAKQRQ | 141 | O96000 | |
| LTKTQELGRDYRTCL | 56 | P22749 | |
| KDYCQVSGSKLRDDT | 91 | Q86YZ3 | |
| KRALSELTQGVTCYK | 1146 | Q96Q89 | |
| ASAKYCQAELKRLSE | 416 | Q96PP9 | |
| ASAKYCQAELKRLSE | 401 | Q8N8V2 | |
| EGCRKSYSRLENLKT | 306 | P08151 | |
| YLRQTRCAEEKATKT | 446 | Q13651 | |
| CTYVGAAKLKELSRR | 316 | Q9P2T1 | |
| IKNVTRSDAGKYRCE | 96 | P57087 | |
| CRKSGLQTDYATEKE | 261 | P46013 | |
| SAERENRYDCLGSKK | 151 | Q14990 | |
| CFREAAYTKRLGTEK | 156 | P04183 | |
| DEACGRQYTLKKTTT | 46 | P14923 | |
| RLKSYCNDQSTGDIK | 101 | P00492 | |
| LKILFCKQSDRGLYT | 296 | Q5VST9 | |
| RYSLRQDGTKCELQI | 3581 | Q5VST9 | |
| LAGCVQRKDYTALTK | 1811 | P46100 | |
| GSLTKCRQIYEEANK | 726 | Q9BZJ0 | |
| KGYSKVLCQTLSERN | 311 | B1AJZ9 | |
| RSNVVRKDYDTLSKC | 266 | Q9UHR4 | |
| CLSVKVNTDGYKRLL | 651 | Q9BXL6 | |
| KKSTNCAYDRIVLRG | 226 | Q13609 | |
| QTYREKLTSKEECLS | 2726 | P49454 | |
| STYFCQIDDRRKKLG | 411 | Q5T197 | |
| YTGEDLTCTVKNLKR | 526 | Q53EP0 | |
| CIEKLYNSSGRDLRR | 111 | Q2V2M9 | |
| GKSDIQDSLCYKTRL | 391 | P57058 | |
| SDCYLDSAKARKLLV | 41 | O75936 | |
| LRTSIYQKCSTLKEA | 606 | Q6ZUT9 | |
| SKLTDREKTNICYLS | 86 | Q8IWF6 | |
| SSSKLYNEVRACREK | 476 | O14744 | |
| DRRAEGKKCTEALYA | 2366 | O15021 | |
| CQYRIATKDRKTVLG | 156 | P40939 | |
| STCYKGLRRLLSKQE | 251 | Q15051 | |
| ENASRAKEYLKGLCS | 61 | O15037 | |
| RADIDKKYRCVSGTQ | 146 | P11279 | |
| SLGYRTKYTARSKCL | 326 | O00219 | |
| GNTTRRCLLEGYDTK | 111 | Q5T8I3 | |
| SGKTNLRRCTYLVLD | 311 | Q92841 | |
| CTYVGAAKLKELSRR | 316 | P36959 | |
| KGLRKYLLGSSDTEC | 491 | Q86UP8 | |
| KGLRKYLLGSSDTEC | 491 | Q6EKJ0 | |
| LSRDSTYKLLKSVCG | 201 | Q96HH9 | |
| YDRGKELNCKSIRDL | 2551 | Q8IVF4 | |
| DTSECYTDSGRKRKR | 416 | Q8N7B9 | |
| KSKFDNLYGCRESLI | 186 | P23526 | |
| KYTRLLAAKVGCDRE | 306 | Q8NFZ4 | |
| YCRAGSLILKSDAAK | 81 | Q08AD1 | |
| SVRALCNGDYDRTIK | 216 | Q86YQ8 | |
| DTGGRKDLTYSVICK | 356 | Q9UF33 | |
| VVCLLSSNRKDKYDA | 556 | Q96J94 | |
| DIRTGTKGYLKCDIS | 191 | Q2WGJ9 | |
| CQRKLGKRYKNSLET | 41 | O43581 | |
| TKTLLGKAVRCYESL | 66 | O14607 | |
| VDEKRTQYIKSRRGC | 516 | Q8IYL2 | |
| YECESKNKVGSQLRS | 666 | P19320 | |
| YSSKAARTGLRICDL | 171 | Q8N142 | |
| VDYGRKELVSCSSLR | 346 | O60522 | |
| AVCRSKSLKAGLDYN | 4621 | Q8WXH0 | |
| KRLYGSVCDLRTNKL | 151 | Q8N9U0 | |
| RKKTESALYGCTVLL | 716 | Q5TCX8 | |
| ISSARKLCGRYLVKE | 26 | Q9Y581 | |
| TRAKANAEKLCTLYE | 1251 | Q9Y2K3 | |
| YLQDGDKNCLVARSK | 41 | Q96NG3 | |
| CSGEKRRREQESKYI | 31 | Q9Y6Q9 | |
| GSCLIERKETNRKFY | 166 | Q96HL8 | |
| NLLVYCKRKSRVTGS | 296 | Q8TCU6 | |
| LKECSGSRKARVLYD | 301 | Q9Y371 | |
| ETSYCFKEKSRGVLR | 126 | Q15475 | |
| YKRCDGRDLTSLRNV | 356 | Q8TCS8 | |
| SRLKDTGYQRLDLCK | 106 | Q9HCE7 | |
| KGKLLCYISLRSATR | 366 | Q9UK61 | |
| DTDKRYCGKTTSRKA | 66 | Q9NY61 | |
| KEISSSLGRLNDCYK | 476 | Q13023 | |
| SLGRLNDCYKEKSRL | 481 | Q13023 | |
| LSRACRIDSTTKLYG | 206 | Q14CN2 | |
| RSKRRKYVFQCTDGS | 1491 | O75094 | |
| KLSISYLRECAKAND | 1356 | Q96JI7 | |
| SGTLKTALLDYIKRC | 2196 | Q96JI7 | |
| SKCGKAYSRSSSLIR | 586 | Q5HYK9 | |
| SLCKKYSRETSQILE | 71 | Q495C1 | |
| YIDDLFKLRSKTSCA | 741 | Q9Y4G8 | |
| KRESKYSGIDEALLC | 71 | Q6B0B8 | |
| SSLDRKYLDGLDVCR | 86 | P38435 | |
| LLRYEKGCVREKQSN | 191 | Q3ZCX4 | |
| RSASLAKLGYLDLCK | 1256 | Q76I76 | |
| LGNKRSLSERTVDKC | 171 | Q496A3 | |
| CALYKEAELRLKGSS | 116 | A1L020 | |
| RLSGCTAKVKQYREE | 421 | Q9P2N2 | |
| LDFTCRLKYLKVSGT | 181 | Q9Y2I1 | |
| GTKSLGNEKRRCIYT | 1296 | Q8WWQ8 | |
| RSKRRKYSFECTDGS | 1496 | O94813 | |
| GSSCKISRDRGKIYF | 61 | Q9BV44 | |
| KSLGKRDLYDEAERC | 251 | Q8NF99 | |
| QGYKTLRLRENCVLS | 171 | P17098 | |
| DEDSIYRCKGKNVRV | 96 | Q8N3Z6 | |
| QSTDPSKYRKRECIS | 696 | Q63HK3 | |
| GSYEKCQDLRALLKR | 66 | Q8TD55 | |
| LCSNGSIRIYDKERL | 46 | Q96FK6 | |
| YGRKRRLTSQDSSEC | 941 | Q9BXT5 | |
| EGNSLICLRKKDYLT | 296 | Q9H6R7 | |
| ICLRKKDYLTGTGQD | 301 | Q9H6R7 | |
| KELLRSQGAECYKLR | 201 | Q52LC2 | |
| CDSGDYKLSLAGRRK | 506 | Q8IWU5 | |
| ERVYSNTKKIGRCIS | 411 | O95932 | |
| NGKYLATCADDRTIR | 101 | Q9Y4P3 | |
| SECGKLFRYNSDLIK | 221 | P17021 | |
| LSCYTGALEVKRKEL | 86 | Q15916 | |
| TTAARRVKYNKGLTC | 176 | O43240 |